Skip to main content

Prescription medicine

Alpha-tocopherol, asorbic acid and 11 other ingredients Brand names: Multiple

Alpha-tocopherol, asorbic acid and 11 other ingredients (Multiple) is a prescription medicine. FDA's NDC Directory lists it from 1 generic labeler.

  • Generic listed

Check it at the source: the alpha-tocopherol, asorbic acid and 11 other ingredients FDA label on DailyMed (effective July 2, 2026); every alpha-tocopherol, asorbic acid and 11 other ingredients label on DailyMed.

Highlights of the record

FDA label of July 2, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Multiple vitamins injection (pediatric) is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.

Forms and strengths

Kit.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 1 under generic applications, 0 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
1 through July 30, 2026

What is alpha-tocopherol, asorbic acid and 11 other ingredients used for?

From the label: indications and usage

Multiple vitamins injection (pediatric) is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. Multiple vitamins injection (pediatric) is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition

Source: FDA drug label (Multiple Vitamins (Pediatric) Pharmacy Bulk Package), Apotex Corp, effective July 2, 2026 (SPL set d9b6eb9a-4218-5c94-6e35-7cbbf0fba494), via openFDA; the full label on DailyMed

Is there a generic for alpha-tocopherol, asorbic acid and 11 other ingredients (Multiple)?

No generic alpha-tocopherol, asorbic acid and 11 other ingredients is approved (Drugs@FDA, October 8, 2026).

FDA's NDC Directory lists alpha-tocopherol, asorbic acid and 11 other ingredients from 1 labeler under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the alpha-tocopherol, asorbic acid and 11 other ingredients label say about other medicines?

The alpha-tocopherol, asorbic acid and 11 other ingredients label names 13 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Ascorbic aciddrug interactionsEffect of multiple vitamins injection (pediatric) on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin
Bleomycindrug interactionsAscorbic acid and riboflavin may reduce the activity of bleomycin
Doxycyclinedrug interactionsEffect of multiple vitamins injection (pediatric) on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin
Erythromycindrug interactionsEffect of multiple vitamins injection (pediatric) on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin
Hydralazinedrug interactionsHydralazine, Isoniazid: Concomitant administration of hydralazine or isoniazid may increase pyridoxine requirements ( 7.2 ).
Isoniaziddrug interactionsHydralazine, Isoniazid: Concomitant administration of hydralazine or isoniazid may increase pyridoxine requirements ( 7.2 ).
Levodopadrug interactionsPyridoxine may decrease blood levels of levodopa and levodopa efficacy may decrease
Lincomycindrug interactionsEffect of multiple vitamins injection (pediatric) on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin
Methotrexatedrug interactionsMethotrexate: Folic acid may decrease response to methotrexate ( 7.1 ) Effects of other drugs on multiple vitamins injection (pediatric):
Multiple vitaminscontraindicationsCONTRAINDICATIONS Multiple vitamins injection (pediatric) is contraindicated in patients who have: An existing hypervitaminosis, or
Phenytoindrug interactionsFolic acid may decrease phenytoin blood levels and increase risk of seizure activity
Streptomycindrug interactionsEffect of multiple vitamins injection (pediatric) on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin
Warfarindrug interactionsIn patients who are co-administered warfarin and multiple vitamins injection (pediatric), blood levels of prothrombin/INR should be monitored to determine if dose of warfarin needs to be adjusted [see Warnings and Precautions ( 5.4 )].

Check alpha-tocopherol, asorbic acid and 11 other ingredients against other medicines

Source: FDA drug label (Multiple Vitamins (Pediatric) Pharmacy Bulk Package), Apotex Corp, effective July 2, 2026 (SPL set d9b6eb9a-4218-5c94-6e35-7cbbf0fba494), via openFDA; the full label on DailyMed

What do FAERS reports show for alpha-tocopherol, asorbic acid and 11 other ingredients?

The FDA Adverse Event Reporting System holds 1 report that list alpha-tocopherol, asorbic acid and 11 other ingredients among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 0 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Unresponsive To Stimuli1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Check an interaction
what two or more labels say about each other